Particulars (Rupees in Crores.) | Mar-2025 | Dec-2024 | Sept-2024 | Jun-2024 | Mar-2024 |
---|---|---|---|---|---|
Gross Sales | 796.9 | 772.4 | 777.3 | 688.4 | 633.8 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 796.9 | 772.4 | 777.3 | 688.4 | 633.8 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 15.3 | 17.8 | 5 | 4.6 | 3.8 |
Total Income | 812.2 | 790.2 | 782.3 | 693 | 637.6 |
Total Expenditure | 598.9 | 585.2 | 559.2 | 509 | 474.9 |
PBIDT | 213.3 | 205 | 223.1 | 184 | 162.7 |
Interest | 26.7 | 25.7 | 19.9 | 17.9 | 16.4 |
PBDT | 186.6 | 179.3 | 203.2 | 166.1 | 146.3 |
Depreciation | 52.6 | 44.7 | 41 | 39 | 46.3 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 35.7 | 35.3 | 44.8 | 33.8 | 28.7 |
Deferred Tax | -7.8 | 6.8 | -3.3 | -1.9 | -0.2 |
Reported Profit After Tax | 106.1 | 92.5 | 120.7 | 95.2 | 71.5 |
Minority Interest After NP | 4.3 | 3.8 | 13.3 | 8.6 | 6 |
Net Profit after Minority Interest | 101.8 | 88.7 | 107.4 | 86.6 | 65.5 |
Extra-ordinary Items | 7.92 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 93.88 | 88.7 | 107.4 | 86.6 | 65.5 |
EPS (Unit Curr.) | 2.54 | 2.22 | 2.68 | 10.82 | 8.18 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 80 | 80 | 80 | 80 | 80 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 26.76 | 26.54 | 28.7 | 26.72 | 25.67 |
PBDTM(%) | 23.41 | 23.21 | 26.14 | 24.12 | 23.08 |
PATM(%) | 13.31 | 11.97 | 15.52 | 13.82 | 11.28 |
Here are some of the stocks that may see significant price movement today: GIC Re, GSK Pharma, Godfrey Philips, etc.
It has entered into a share purchase agreement to acquire a 100% equity stake in Chalasani Hospitals Pvt Ltd.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.